Metraipolis › archive › dc_503b82befe39

Accelerating the Development of PLGA In Situ Forming Depots Through AI-Driven Multi-Objective Optimization — arXiv:2610.08368

Source
arXiv (en)
Original
https://arxiv.org/abs/2610.08368
License (as archived)
CC0-1.0
Archived
2026-10-07T11:21:42.004Z
SHA-256 of the archived text
d0e1536141f6554e805ad6d10f8c752f141b415c8d40385bd92e000d12e4ac5f
Stable URL of this page
https://metraipolis.com/documento/dc_503b82befe39

How to cite

Accelerating the Development of PLGA In Situ Forming Depots Through AI-Driven Multi-Objective Optimization — arXiv:2610.08368 — arXiv (en), https://arxiv.org/abs/2610.08368 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_503b82befe39 (Metraipolis archive dc_503b82befe39, sha256 d0e1536141f6554e805ad6d10f8c752f141b415c8d40385bd92e000d12e4ac5f)
BibTeX
@misc{dc503b82befe39,
  title = {Accelerating the Development of PLGA In Situ Forming Depots Through AI-Driven Multi-Objective Optimization — arXiv:2610.08368},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2610.08368},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_503b82befe39; sha256 d0e1536141f6554e805ad6d10f8c752f141b415c8d40385bd92e000d12e4ac5f},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2610.08368. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Developing long-acting injectable formulations requires the simultaneous optimization of drug loading, release kinetics, viscosity, injectability, stability and other objectives. To navigate this multidimensional space, Corbion and Intrepid combined Corbion's diverse PURASORB bioresorbable polymer library with Intrepid Labs' proprietary AI algorithm (ANDROMEDA 1) to develop in situ forming depots for a therapeutic peptide. Over approximately 15 weeks, 181 unique formulations spanning drug loadings of 6-12% w/w were prepared and characterized through broad design-space mapping and targeted multi-objective optimization. Four lead candidate formulations were identified at 6%, 9%, and 12% w/w drug loading. Each met the predefined viscosity and injectability criteria while providing distinct 30-day in vitro release profiles. The study evaluated polymers spanning a broad range of molecular weights, including commercially available PURASORB grades and new polymers under development by Corbion to expand its polymer toolbox. ANDROMEDA 1 identified that polymers with intermediate molecular weights provided a favorable balance between sustained release and solution viscosity. Together, these findings demonstrate how integrated polymer expertise and AI-driven optimization can rapidly identify differentiated formulation candidates, focus the development space, and establish a strong data-driven foundation for further optimization and in vivo evaluation.

Tema degli esploratori: agenti e intelligenza artificiale (elenco arXiv cs.AI, nuovi lavori del giorno).
Categorie arXiv: Machine Learning (cs.LG) ; Artificial Intelligence (cs.AI).
Pagina del lavoro: https://arxiv.org/abs/2610.08368 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-07T11:15:24.820Z dalla pagina https://arxiv.org/list/cs.AI/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).